Molecular imaging enables earlier, individualized treatment of thyroid cancer

January 05, 2009

Physicians now able to accurately distinguish cancerous lymph nodes from healthy tissue in cancer patients, according to article in the Journal of Nuclear Medicine

Reston, Va.-In a study to determine the diagnostic value of molecular imaging in nodal staging of patients with thyroid cancer, researchers were able for the first time to accurately distinguish between cancerous cells in regional lymph nodes and normal residual thyroid tissue directly after surgery.

Researchers from the University of Erlangen-Nürnberg, Germany, reported in an article in the January issue of The Journal of Nuclear Medicine on the results of a study using a hybrid single photon emission computed tomography-computed tomography (SPECT-CT) camera to determine and locate the spread of cancer cells to nearby lymph nodes.

According to the researchers, the demonstration or exclusion of cancer spread (metastasis) in regional lymph nodes plays a major role in treating the disease since all patients with lymph node metastases are considered to be at high risk for recurrence.

Currently, patients with differentiated thyroid carcinoma (DTC) who have had their thyroid removed are treated with radioactive iodine, which effectively zeros in on and kills any remaining cancerous thyroid cells. Because one of the functions of the thyroid gland is to absorb iodine from the blood, radioiodine is taken up by any thyroid tissue not removed by surgery, including cancerous cells spreading to other body parts, such as lymph nodes. In addition to emitting electrons that destroy the tissue harboring the radionuclide, radioactive iodine emits photons suitable for imaging.

"Normal thyroid tissue as well as residual cancer cells concentrate radioiodine. Performed after ingestion of radioiodine, SPECT-CT provides three-dimensional images of the distribution of the radionuclide in the human body and is therefore used for staging this type of cancer," said Torsten Kuwert, MD, co-author of the article. "Incorporated at first treatment, SPECT-CT allows us to better stratify patients into treatment groups."

In the study, 57 patients received radioiodine therapy. Afterwards, a SPECT-CT camera was rotated around the patients at a variety of angles to capture where the radioactivity was occurring. SPECT imaging can locate cells in the body that are not behaving normally, but does not provide the detailed, X-ray-like images that CT imaging can. The hybrid camera, however, is able to reveal both the malignant cell activity and the exact anatomical location.

"With SPECT-CT imaging, we were able to determine tumor spread much earlier than before," said Daniela Schmidt, MD, another co-author of the article. "Earlier detection will lead to earlier individualized treatment of this potentially deadly cancer."

The researchers also reported that this information led to a revision of the original diagnosis in 35 percent of the study participants. The images reclassified as benign six of 11 lesions that had been considered lymph node metastases and 11 of 15 lesions considered to be indeterminate.

"Our data suggest that SPECT-CT should be used as a routine procedure in DTC patients at the first radioiodine treatment," said Kuwert. "By upstaging or downstaging disease, this hybrid imaging tool may alter the management of more than one-third of patients with the disease."

According to the American Cancer Society, DTC is the most common form of thyroid cancer and one of the success stories in the war on cancer. Since the advent of radioiodine therapy, it has been considered one of the more curable cancers. In 2009, about 37,340 new cases of thyroid cancer will be diagnosed in the United States. Of the new cases, about 28,410 will occur in women, and 8,930 in men.

Society of Nuclear Medicine

---

---

	Thyroid Cancer: A Guide for Patients by Douglas Van Nostrand (Author), MD (Author), FACP (Author), FACNM (Author), Leonard Wartofsky (Author), MPH (Author), MACP (Author), Gary Bloom (Author), Kanchan Kulkarni (Author), MBBA (Author), Douglas Van Nostrand (Editor), MD (Editor), FACP (Editor), FACNM (Editor), Leonard Wartofsky (Editor), MPH (Editor), MACP (Editor), Gary Bloom (Editor), Kanchan Kulkarni (Editor), MBBA (Editor) The objectives of this book are two fold: (1) to offer an understandable source of information to educate the patient who has thyroid cancer as well as the patient's family members and friends, and (2) to improve not only the patient's quality of medical care but also the patient's support from family and friends.
	Dirty Bombshell: From Thyroid Cancer Back To Fabulous! by Lorna J Brunelle (Author) A treasured read. I learned, laughed, and cried. I will pass on this remarkable resource. - Dawn Eger Rizzo, Thyroid Cancer Survivor Unflappable, witty, honest, and inspirational describe Lorna's exploration of her journey. As a survivor of kidney cancer, I was awed, captivated, and encouraged by the positive nature of Lorna's personal philosophy. - Marsha E. Bergquist, Cancer Survivor Having suffered much loss from this disease, Lorna's narrative about dealing with thyroid cancer is not only filled with useful and practical information, but was cathartic for my own repressed emotions. I laughed, I cried, and I healed. - Ellie Osborne Lorna has the innate gift of bringing light, laughter, and hope while sharing her journey with readers. I was pulled in...
	The Thyroid Cancer Book by M. Sara Rosenthal Ph.D. (Author) Now in its second edition, the only consumer book on thyroid cancer in plain language, also contains a Low Iodine Cookbook. Recommended by Johns Hopkins Thyroid Tumor Center, The Thyroid Foundation of America, The American Foundation for Thyroid Patients, The Thyroid Foundation of Canada, CancerHelpUK, and thyroid cancer patients from both Thyca and Thry'Vors.
	Everything Changes: The Insider's Guide to Cancer in Your 20's and 30's by Kairol Rosenthal (Author) "By page three of the introduction to Everything Changes, I wanted not only to devour the rest of the book, but I wanted to call Kairol up, get to know her, and (if we weren't both already married) see if I could sleep with her. Then the book got really good. It is, without doubt, the most forthright, emotionally sophisticated, and plain-old valuable book of its kind I've seen. The book defines and exemplifies what the verb 'fight' really means: to arm, prepare, and engage in sustained effort to gain a desired end. If that's your mission, this is your instruction manual." —Evan Handler, actor and author of Time On Fire and It's Only Temporary: The Good News and the Bad News of Being Alive (and a guy who got well from acute myeloid leukemia in 1985)On a shoestring budget and with tape...
	Thyroid Cancer: A Comprehensive Guide to Clinical Management by Leonard Wartofsky (Editor), Douglas Van Nostrand (Editor) This massive revision of the highly acclaimed first edition presents a wealth of new information and insights on every aspect of the etiology, pathogenesis, diagnosis, initial treatment, and long-term management of all varieties of thyroid cancer. Paramount is a thorough treatment of the nuclear medical aspects of diagnosing and managing the thyroid cancer patient. This includes extensive discussion of isotopes, isotope uptake and scanning procedures, radioisodine ablation and dosimetry (with or without recombinant human TSH), stunning, octreotide and FDG-PET scanning, and various alternative imaging modalities. Additional highlights include management of the scan negative and thyroglobulin-positive patient, ultrasound of the lymph nodes, local adjuncts to therapy of metastases, low...
	QuickFACTS Thyroid Cancer by American Cancer Society (Author) More than 200,000 men worldwide will contract thyroid cancer this year, and this book emphasizes that all patients should be well-informed decision-makers in planning their own treatment. Covering everything from risk factors to living well after cancer treatment, this pocket-sized reference provides critical questions to ask your healthcare team, is updated with the latest patient treatment guidelines, and includes an advanced dictionary of cancer-related terms.
	The Thyroid Sourcebook (5th Edition) (Sourcebooks) by M. Sara Rosenthal (Author) The classic reference guide for living with thyroid disorder--now completely revised and updated The New York Times called this book "an excellent source of information." The Thyroid Sourcebook features patient narratives; information on the complications of hypo- and hyperthyroidism, such as depression, weight gain, thyroid, eye disease, and sleep disorders; the latest on complimentary medicine; and much more.
	Practical Management of Thyroid Cancer: A Multidisciplinary Approach by Ernest L. Mazzaferri (Editor), Clive Harmer (Editor), Ujjal K. Mallick (Editor), Pat Kendall-Taylor (Editor) Written by a multidisciplinary team of experts involved in the development of standards and guidelines for its management in the USA, UK, Europe and Asia, the book contains succinct and knowledgeable summaries of the management of thyroid cancer. Every chapter describes a different aspect of care, and provides clear and detailed information about caring for patients with this group of tumors. This is an invaluable reference to health care professionals, from primary to tertiary care, involved in the management of thyroid cancer such as clinical nurse specialists, clinical psychologists, family medicine practitioners, specialists in palliative care (especially for anaplastic thyroid cancers), geneticists and surgeons, endocrinologists, oncologists, pathologists, and radiologists.
	The Complete Thyroid Book, Second Edition by Kenneth Ain (Author), M. Sara Rosenthal (Author) The only book you need to understand and treat your thyroid condition Combining the expertise of two pioneers in the field--world-renowned thyroid specialist Kenneth Ain, M.D., and bestselling thyroid author and bioethicist M. Sara Rosenthal, Ph.D.--The Complete Thyroid Book provides all the essential information on the diagnosis, options, and treatment of thyroid disease. Completely updated with the latest research, this book provides a comprehensive look at tests, scans, and state-of-the-art therapies and treatments for every type of thyroid condition. The Complete Thyroid Book, now revised and updated, is your source for information on: Thyroid hormone and all other medications used in thyroid treatment Thyroid disease in special populations, including...
	Thyroid Cancer by H.-J. Biersack (Editor), F. Grünwald (Editor) The emergence of novel diagnostic and therapeutic concepts calls for the publication of a new volume on thyroid cancer. This book describes all current diagnostic techniques, including FDG-PET and MRI. In recent years these modalities have documented hitherto hidden radioiodine-negative metastases, thus improving surgical therapy. The whole gamut of treatment, including surgery, radioiodine therapy, percutaneous radiation therapy and medical management, is covered. In some 10% of differentiated thyroid cancers, the well-known treatment tools of surgery and radioiodine therapy are not sufficient. New treatment modalities such as high-dose radioiodine therapy, redifferentiation therapy with retinoic acid and recombinant TSH are therefore highlighted. In a special section devoted to...